These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6987848)

  • 41. Increase in colony-forming capacity of the haemopoietic stem cells in the bone marrow exposed to the He-Ne laser radiation in vitro.
    Vacek A; Bartonícková A; Veselá Z; Petrů F
    Folia Biol (Praha); 1982; 28(6):426-30. PubMed ID: 7160492
    [No Abstract]   [Full Text] [Related]  

  • 42. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N; Chertkov J; Zander A
    Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression.
    Kondo S; Yin D; Morimura T; Oda Y; Kikuchi H; Takeuchi J
    Cancer Res; 1994 Jun; 54(11):2928-33. PubMed ID: 7514494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The biology of hematopoietic stem cells.
    Ratajczak MZ; Gewirtz AM
    Semin Oncol; 1995 Jun; 22(3):210-7. PubMed ID: 7777865
    [No Abstract]   [Full Text] [Related]  

  • 46. [Correction of changes in populations of hematopoietic progenitor cells induced by testosterone using an inhibitor of cellular proliferative activity of hematopoietic stem cells].
    Orlovskaia IA; Khaldoianidi SK; Shklovskaia EV; Tsyrlova IG; Kozlov VA
    Biull Eksp Biol Med; 1995 Oct; 120(10):394-7. PubMed ID: 8595230
    [No Abstract]   [Full Text] [Related]  

  • 47. [Methods of determining blast cell sensitivity to chemical preparations in treating leukemias (a review of the literature)].
    Evtukh VP
    Vrach Delo; 1986 Aug; (8):42-6. PubMed ID: 3535253
    [No Abstract]   [Full Text] [Related]  

  • 48. Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs.
    Drewinko B; Barlogie B
    Cancer Treat Rep; 1976 Dec; 60(12):1707-17. PubMed ID: 1026329
    [No Abstract]   [Full Text] [Related]  

  • 49. Evidence for recruitment and synchronization in leukemia and solid tumors.
    Mauer AM; Murphy SB; Hayes FA
    Cancer Treat Rep; 1976 Dec; 60(12):1841-4. PubMed ID: 1026338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are cell kinetic data relevant for the design of tumour chemotherapy schedules?
    van Putten LM
    Cell Tissue Kinet; 1974 Sep; 7(5):493-504. PubMed ID: 4607700
    [No Abstract]   [Full Text] [Related]  

  • 51. Current therapy of acute leukoses and myelosuppressive effect of cytostatics in the course of treatment.
    Hauptmann E
    Lijec Vjesn; 1978 Jun; 100(6):376. PubMed ID: 703494
    [No Abstract]   [Full Text] [Related]  

  • 52. [History and significance to giant cells caused by mitosis inhibition].
    Marinone G; Baserga A
    Minerva Med; 1975 Jul; 66(49):2367-77. PubMed ID: 1056511
    [No Abstract]   [Full Text] [Related]  

  • 53. Human tumor stem-cell assay.
    N Engl J Med; 1983 Jun; 308(24):1478-81. PubMed ID: 6855820
    [No Abstract]   [Full Text] [Related]  

  • 54. The action of chemotherapeutic agents at the cellular level and the effects of these agents on hematopoietic and lymphomatous tissue.
    Bruce WR
    Proc Can Cancer Conf; 1967; 7():53-64. PubMed ID: 6047866
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of a new antitumor agent, epipodophyllotoxin, on growth and chromosomes in human hematopoietic cell lines.
    Huang CC; Hou Y; Wang JJ
    Cancer Res; 1973 Dec; 33(12):3123-9. PubMed ID: 4760528
    [No Abstract]   [Full Text] [Related]  

  • 56. Mosaicism induced by gene insertion as a means of improving chemotherapeutic selectivity.
    Moolten FL
    Crit Rev Immunol; 1990; 10(3):203-33. PubMed ID: 2085408
    [No Abstract]   [Full Text] [Related]  

  • 57. [Myelosuppressive effect of cytostatics in the intensive chemotherapy of solid tumors].
    Kolarić K
    Lijec Vjesn; 1978 Jun; 100(6):378. PubMed ID: 703496
    [No Abstract]   [Full Text] [Related]  

  • 58. Synergistic interaction of anticancer agents: a cellular perspective.
    Valeriote F; Lin Hs
    Cancer Chemother Rep; 1975; 59(5):895-900. PubMed ID: 1203896
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of an 'in vitro' sensitivity test for human leukemic cells.
    Bhisey AN; Kavi BR; Gollerkeri MP; Ranadive KJ
    Indian J Cancer; 1975 Sep; 12(3):302-9. PubMed ID: 1193662
    [No Abstract]   [Full Text] [Related]  

  • 60. Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.
    Van Putten LM; Lelieveld P; Kram-Idsenga LK
    Cancer Chemother Rep; 1972 Dec; 56(6):691-700. PubMed ID: 4512950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.